Global Glucagon Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Glucagon Drug market size was valued at USD 591.6 million in 2023 and is forecast to a readjusted size of USD 880.1 million by 2030 with a CAGR of 5.8% during review period.

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream.  Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.

The Glucagon injection market is driven by the rising prevalence of diabetes and hypoglycemia, and the growing awareness of the importance of emergency treatment for severe low blood sugar episodes. Glucagon injections are life-saving emergency medications used to rapidly raise blood sugar levels in individuals experiencing severe hypoglycemia. The rise in the global diabetic population and the need for effective management of insulin-related conditions contribute to market growth as glucagon injections offer a crucial solution in emergency situations. Moreover, advancements in device design and the development of user-friendly glucagon delivery systems have improved the accessibility and ease of administration. However, the market also faces challenges, including the need for patient education on proper administration and storage of glucagon injections, and the complexity of the regulatory landscape for medical emergency medications. Additionally, addressing affordability and expanding access to glucagon injections in various regions can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and reliable glucagon injection solutions, collaborate with healthcare providers to promote awareness and training, and address the challenges to meet the increasing demand for effective and life-saving emergency treatments for hypoglycemia.

The Global Info Research report includes an overview of the development of the Glucagon Drug industry chain, the market status of Hospital (Vials, Prefilled), Pharmacy (Vials, Prefilled), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Glucagon Drug.

Regionally, the report analyzes the Glucagon Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Glucagon Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Glucagon Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Glucagon Drug industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Vials, Prefilled).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Glucagon Drug market.

Regional Analysis: The report involves examining the Glucagon Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Glucagon Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Glucagon Drug:
Company Analysis: Report covers individual Glucagon Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Glucagon Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Pharmacy).

Technology Analysis: Report covers specific technologies relevant to Glucagon Drug. It assesses the current state, advancements, and potential future developments in Glucagon Drug areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Glucagon Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Glucagon Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Vials
    Prefilled

Market segment by Application
    Hospital
    Pharmacy

Major players covered
    Novo Nordisk
    Eli Lilly
    Fresenius Kabi
    Torrent Labs
    Amphastar Pharmaceuticals
    Xeris Pharmaceuticals

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glucagon Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Glucagon Drug, with price, sales, revenue and global market share of Glucagon Drug from 2019 to 2024.
Chapter 3, the Glucagon Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glucagon Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Glucagon Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Glucagon Drug.
Chapter 14 and 15, to describe Glucagon Drug sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Glucagon Drug
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Glucagon Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Vials
        1.3.3 Prefilled
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Glucagon Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospital
        1.4.3 Pharmacy
    1.5 Global Glucagon Drug Market Size & Forecast
        1.5.1 Global Glucagon Drug Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Glucagon Drug Sales Quantity (2019-2030)
        1.5.3 Global Glucagon Drug Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Novo Nordisk
        2.1.1 Novo Nordisk Details
        2.1.2 Novo Nordisk Major Business
        2.1.3 Novo Nordisk Glucagon Drug Product and Services
        2.1.4 Novo Nordisk Glucagon Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Novo Nordisk Recent Developments/Updates
    2.2 Eli Lilly
        2.2.1 Eli Lilly Details
        2.2.2 Eli Lilly Major Business
        2.2.3 Eli Lilly Glucagon Drug Product and Services
        2.2.4 Eli Lilly Glucagon Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Eli Lilly Recent Developments/Updates
    2.3 Fresenius Kabi
        2.3.1 Fresenius Kabi Details
        2.3.2 Fresenius Kabi Major Business
        2.3.3 Fresenius Kabi Glucagon Drug Product and Services
        2.3.4 Fresenius Kabi Glucagon Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Fresenius Kabi Recent Developments/Updates
    2.4 Torrent Labs
        2.4.1 Torrent Labs Details
        2.4.2 Torrent Labs Major Business
        2.4.3 Torrent Labs Glucagon Drug Product and Services
        2.4.4 Torrent Labs Glucagon Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Torrent Labs Recent Developments/Updates
    2.5 Amphastar Pharmaceuticals
        2.5.1 Amphastar Pharmaceuticals Details
        2.5.2 Amphastar Pharmaceuticals Major Business
        2.5.3 Amphastar Pharmaceuticals Glucagon Drug Product and Services
        2.5.4 Amphastar Pharmaceuticals Glucagon Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Amphastar Pharmaceuticals Recent Developments/Updates
    2.6 Xeris Pharmaceuticals
        2.6.1 Xeris Pharmaceuticals Details
        2.6.2 Xeris Pharmaceuticals Major Business
        2.6.3 Xeris Pharmaceuticals Glucagon Drug Product and Services
        2.6.4 Xeris Pharmaceuticals Glucagon Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Xeris Pharmaceuticals Recent Developments/Updates

3 Competitive Environment: Glucagon Drug by Manufacturer
    3.1 Global Glucagon Drug Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Glucagon Drug Revenue by Manufacturer (2019-2024)
    3.3 Global Glucagon Drug Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Glucagon Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Glucagon Drug Manufacturer Market Share in 2023
        3.4.2 Top 6 Glucagon Drug Manufacturer Market Share in 2023
    3.5 Glucagon Drug Market: Overall Company Footprint Analysis
        3.5.1 Glucagon Drug Market: Region Footprint
        3.5.2 Glucagon Drug Market: Company Product Type Footprint
        3.5.3 Glucagon Drug Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Glucagon Drug Market Size by Region
        4.1.1 Global Glucagon Drug Sales Quantity by Region (2019-2030)
        4.1.2 Global Glucagon Drug Consumption Value by Region (2019-2030)
        4.1.3 Global Glucagon Drug Average Price by Region (2019-2030)
    4.2 North America Glucagon Drug Consumption Value (2019-2030)
    4.3 Europe Glucagon Drug Consumption Value (2019-2030)
    4.4 Asia-Pacific Glucagon Drug Consumption Value (2019-2030)
    4.5 South America Glucagon Drug Consumption Value (2019-2030)
    4.6 Middle East and Africa Glucagon Drug Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Glucagon Drug Sales Quantity by Type (2019-2030)
    5.2 Global Glucagon Drug Consumption Value by Type (2019-2030)
    5.3 Global Glucagon Drug Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Glucagon Drug Sales Quantity by Application (2019-2030)
    6.2 Global Glucagon Drug Consumption Value by Application (2019-2030)
    6.3 Global Glucagon Drug Average Price by Application (2019-2030)

7 North America
    7.1 North America Glucagon Drug Sales Quantity by Type (2019-2030)
    7.2 North America Glucagon Drug Sales Quantity by Application (2019-2030)
    7.3 North America Glucagon Drug Market Size by Country
        7.3.1 North America Glucagon Drug Sales Quantity by Country (2019-2030)
        7.3.2 North America Glucagon Drug Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Glucagon Drug Sales Quantity by Type (2019-2030)
    8.2 Europe Glucagon Drug Sales Quantity by Application (2019-2030)
    8.3 Europe Glucagon Drug Market Size by Country
        8.3.1 Europe Glucagon Drug Sales Quantity by Country (2019-2030)
        8.3.2 Europe Glucagon Drug Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Glucagon Drug Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Glucagon Drug Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Glucagon Drug Market Size by Region
        9.3.1 Asia-Pacific Glucagon Drug Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Glucagon Drug Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Glucagon Drug Sales Quantity by Type (2019-2030)
    10.2 South America Glucagon Drug Sales Quantity by Application (2019-2030)
    10.3 South America Glucagon Drug Market Size by Country
        10.3.1 South America Glucagon Drug Sales Quantity by Country (2019-2030)
        10.3.2 South America Glucagon Drug Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Glucagon Drug Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Glucagon Drug Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Glucagon Drug Market Size by Country
        11.3.1 Middle East & Africa Glucagon Drug Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Glucagon Drug Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Glucagon Drug Market Drivers
    12.2 Glucagon Drug Market Restraints
    12.3 Glucagon Drug Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Glucagon Drug and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Glucagon Drug
    13.3 Glucagon Drug Production Process
    13.4 Glucagon Drug Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Glucagon Drug Typical Distributors
    14.3 Glucagon Drug Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Glucagon Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Glucagon Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
    Table 4. Novo Nordisk Major Business
    Table 5. Novo Nordisk Glucagon Drug Product and Services
    Table 6. Novo Nordisk Glucagon Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Novo Nordisk Recent Developments/Updates
    Table 8. Eli Lilly Basic Information, Manufacturing Base and Competitors
    Table 9. Eli Lilly Major Business
    Table 10. Eli Lilly Glucagon Drug Product and Services
    Table 11. Eli Lilly Glucagon Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Eli Lilly Recent Developments/Updates
    Table 13. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
    Table 14. Fresenius Kabi Major Business
    Table 15. Fresenius Kabi Glucagon Drug Product and Services
    Table 16. Fresenius Kabi Glucagon Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Fresenius Kabi Recent Developments/Updates
    Table 18. Torrent Labs Basic Information, Manufacturing Base and Competitors
    Table 19. Torrent Labs Major Business
    Table 20. Torrent Labs Glucagon Drug Product and Services
    Table 21. Torrent Labs Glucagon Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Torrent Labs Recent Developments/Updates
    Table 23. Amphastar Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 24. Amphastar Pharmaceuticals Major Business
    Table 25. Amphastar Pharmaceuticals Glucagon Drug Product and Services
    Table 26. Amphastar Pharmaceuticals Glucagon Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Amphastar Pharmaceuticals Recent Developments/Updates
    Table 28. Xeris Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 29. Xeris Pharmaceuticals Major Business
    Table 30. Xeris Pharmaceuticals Glucagon Drug Product and Services
    Table 31. Xeris Pharmaceuticals Glucagon Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Xeris Pharmaceuticals Recent Developments/Updates
    Table 33. Global Glucagon Drug Sales Quantity by Manufacturer (2019-2024) & (K Units)
    Table 34. Global Glucagon Drug Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 35. Global Glucagon Drug Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 36. Market Position of Manufacturers in Glucagon Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 37. Head Office and Glucagon Drug Production Site of Key Manufacturer
    Table 38. Glucagon Drug Market: Company Product Type Footprint
    Table 39. Glucagon Drug Market: Company Product Application Footprint
    Table 40. Glucagon Drug New Market Entrants and Barriers to Market Entry
    Table 41. Glucagon Drug Mergers, Acquisition, Agreements, and Collaborations
    Table 42. Global Glucagon Drug Sales Quantity by Region (2019-2024) & (K Units)
    Table 43. Global Glucagon Drug Sales Quantity by Region (2025-2030) & (K Units)
    Table 44. Global Glucagon Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 45. Global Glucagon Drug Consumption Value by Region (2025-2030) & (USD Million)
    Table 46. Global Glucagon Drug Average Price by Region (2019-2024) & (US$/Unit)
    Table 47. Global Glucagon Drug Average Price by Region (2025-2030) & (US$/Unit)
    Table 48. Global Glucagon Drug Sales Quantity by Type (2019-2024) & (K Units)
    Table 49. Global Glucagon Drug Sales Quantity by Type (2025-2030) & (K Units)
    Table 50. Global Glucagon Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 51. Global Glucagon Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 52. Global Glucagon Drug Average Price by Type (2019-2024) & (US$/Unit)
    Table 53. Global Glucagon Drug Average Price by Type (2025-2030) & (US$/Unit)
    Table 54. Global Glucagon Drug Sales Quantity by Application (2019-2024) & (K Units)
    Table 55. Global Glucagon Drug Sales Quantity by Application (2025-2030) & (K Units)
    Table 56. Global Glucagon Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 57. Global Glucagon Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 58. Global Glucagon Drug Average Price by Application (2019-2024) & (US$/Unit)
    Table 59. Global Glucagon Drug Average Price by Application (2025-2030) & (US$/Unit)
    Table 60. North America Glucagon Drug Sales Quantity by Type (2019-2024) & (K Units)
    Table 61. North America Glucagon Drug Sales Quantity by Type (2025-2030) & (K Units)
    Table 62. North America Glucagon Drug Sales Quantity by Application (2019-2024) & (K Units)
    Table 63. North America Glucagon Drug Sales Quantity by Application (2025-2030) & (K Units)
    Table 64. North America Glucagon Drug Sales Quantity by Country (2019-2024) & (K Units)
    Table 65. North America Glucagon Drug Sales Quantity by Country (2025-2030) & (K Units)
    Table 66. North America Glucagon Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 67. North America Glucagon Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 68. Europe Glucagon Drug Sales Quantity by Type (2019-2024) & (K Units)
    Table 69. Europe Glucagon Drug Sales Quantity by Type (2025-2030) & (K Units)
    Table 70. Europe Glucagon Drug Sales Quantity by Application (2019-2024) & (K Units)
    Table 71. Europe Glucagon Drug Sales Quantity by Application (2025-2030) & (K Units)
    Table 72. Europe Glucagon Drug Sales Quantity by Country (2019-2024) & (K Units)
    Table 73. Europe Glucagon Drug Sales Quantity by Country (2025-2030) & (K Units)
    Table 74. Europe Glucagon Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 75. Europe Glucagon Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 76. Asia-Pacific Glucagon Drug Sales Quantity by Type (2019-2024) & (K Units)
    Table 77. Asia-Pacific Glucagon Drug Sales Quantity by Type (2025-2030) & (K Units)
    Table 78. Asia-Pacific Glucagon Drug Sales Quantity by Application (2019-2024) & (K Units)
    Table 79. Asia-Pacific Glucagon Drug Sales Quantity by Application (2025-2030) & (K Units)
    Table 80. Asia-Pacific Glucagon Drug Sales Quantity by Region (2019-2024) & (K Units)
    Table 81. Asia-Pacific Glucagon Drug Sales Quantity by Region (2025-2030) & (K Units)
    Table 82. Asia-Pacific Glucagon Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 83. Asia-Pacific Glucagon Drug Consumption Value by Region (2025-2030) & (USD Million)
    Table 84. South America Glucagon Drug Sales Quantity by Type (2019-2024) & (K Units)
    Table 85. South America Glucagon Drug Sales Quantity by Type (2025-2030) & (K Units)
    Table 86. South America Glucagon Drug Sales Quantity by Application (2019-2024) & (K Units)
    Table 87. South America Glucagon Drug Sales Quantity by Application (2025-2030) & (K Units)
    Table 88. South America Glucagon Drug Sales Quantity by Country (2019-2024) & (K Units)
    Table 89. South America Glucagon Drug Sales Quantity by Country (2025-2030) & (K Units)
    Table 90. South America Glucagon Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 91. South America Glucagon Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 92. Middle East & Africa Glucagon Drug Sales Quantity by Type (2019-2024) & (K Units)
    Table 93. Middle East & Africa Glucagon Drug Sales Quantity by Type (2025-2030) & (K Units)
    Table 94. Middle East & Africa Glucagon Drug Sales Quantity by Application (2019-2024) & (K Units)
    Table 95. Middle East & Africa Glucagon Drug Sales Quantity by Application (2025-2030) & (K Units)
    Table 96. Middle East & Africa Glucagon Drug Sales Quantity by Region (2019-2024) & (K Units)
    Table 97. Middle East & Africa Glucagon Drug Sales Quantity by Region (2025-2030) & (K Units)
    Table 98. Middle East & Africa Glucagon Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 99. Middle East & Africa Glucagon Drug Consumption Value by Region (2025-2030) & (USD Million)
    Table 100. Glucagon Drug Raw Material
    Table 101. Key Manufacturers of Glucagon Drug Raw Materials
    Table 102. Glucagon Drug Typical Distributors
    Table 103. Glucagon Drug Typical Customers
List of Figures
    Figure 1. Glucagon Drug Picture
    Figure 2. Global Glucagon Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Glucagon Drug Consumption Value Market Share by Type in 2023
    Figure 4. Vials Examples
    Figure 5. Prefilled Examples
    Figure 6. Global Glucagon Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 7. Global Glucagon Drug Consumption Value Market Share by Application in 2023
    Figure 8. Hospital Examples
    Figure 9. Pharmacy Examples
    Figure 10. Global Glucagon Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 11. Global Glucagon Drug Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 12. Global Glucagon Drug Sales Quantity (2019-2030) & (K Units)
    Figure 13. Global Glucagon Drug Average Price (2019-2030) & (US$/Unit)
    Figure 14. Global Glucagon Drug Sales Quantity Market Share by Manufacturer in 2023
    Figure 15. Global Glucagon Drug Consumption Value Market Share by Manufacturer in 2023
    Figure 16. Producer Shipments of Glucagon Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 17. Top 3 Glucagon Drug Manufacturer (Consumption Value) Market Share in 2023
    Figure 18. Top 6 Glucagon Drug Manufacturer (Consumption Value) Market Share in 2023
    Figure 19. Global Glucagon Drug Sales Quantity Market Share by Region (2019-2030)
    Figure 20. Global Glucagon Drug Consumption Value Market Share by Region (2019-2030)
    Figure 21. North America Glucagon Drug Consumption Value (2019-2030) & (USD Million)
    Figure 22. Europe Glucagon Drug Consumption Value (2019-2030) & (USD Million)
    Figure 23. Asia-Pacific Glucagon Drug Consumption Value (2019-2030) & (USD Million)
    Figure 24. South America Glucagon Drug Consumption Value (2019-2030) & (USD Million)
    Figure 25. Middle East & Africa Glucagon Drug Consumption Value (2019-2030) & (USD Million)
    Figure 26. Global Glucagon Drug Sales Quantity Market Share by Type (2019-2030)
    Figure 27. Global Glucagon Drug Consumption Value Market Share by Type (2019-2030)
    Figure 28. Global Glucagon Drug Average Price by Type (2019-2030) & (US$/Unit)
    Figure 29. Global Glucagon Drug Sales Quantity Market Share by Application (2019-2030)
    Figure 30. Global Glucagon Drug Consumption Value Market Share by Application (2019-2030)
    Figure 31. Global Glucagon Drug Average Price by Application (2019-2030) & (US$/Unit)
    Figure 32. North America Glucagon Drug Sales Quantity Market Share by Type (2019-2030)
    Figure 33. North America Glucagon Drug Sales Quantity Market Share by Application (2019-2030)
    Figure 34. North America Glucagon Drug Sales Quantity Market Share by Country (2019-2030)
    Figure 35. North America Glucagon Drug Consumption Value Market Share by Country (2019-2030)
    Figure 36. United States Glucagon Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 37. Canada Glucagon Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 38. Mexico Glucagon Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Europe Glucagon Drug Sales Quantity Market Share by Type (2019-2030)
    Figure 40. Europe Glucagon Drug Sales Quantity Market Share by Application (2019-2030)
    Figure 41. Europe Glucagon Drug Sales Quantity Market Share by Country (2019-2030)
    Figure 42. Europe Glucagon Drug Consumption Value Market Share by Country (2019-2030)
    Figure 43. Germany Glucagon Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 44. France Glucagon Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 45. United Kingdom Glucagon Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. Russia Glucagon Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. Italy Glucagon Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Asia-Pacific Glucagon Drug Sales Quantity Market Share by Type (2019-2030)
    Figure 49. Asia-Pacific Glucagon Drug Sales Quantity Market Share by Application (2019-2030)
    Figure 50. Asia-Pacific Glucagon Drug Sales Quantity Market Share by Region (2019-2030)
    Figure 51. Asia-Pacific Glucagon Drug Consumption Value Market Share by Region (2019-2030)
    Figure 52. China Glucagon Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 53. Japan Glucagon Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 54. Korea Glucagon Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. India Glucagon Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Southeast Asia Glucagon Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Australia Glucagon Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. South America Glucagon Drug Sales Quantity Market Share by Type (2019-2030)
    Figure 59. South America Glucagon Drug Sales Quantity Market Share by Application (2019-2030)
    Figure 60. South America Glucagon Drug Sales Quantity Market Share by Country (2019-2030)
    Figure 61. South America Glucagon Drug Consumption Value Market Share by Country (2019-2030)
    Figure 62. Brazil Glucagon Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 63. Argentina Glucagon Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 64. Middle East & Africa Glucagon Drug Sales Quantity Market Share by Type (2019-2030)
    Figure 65. Middle East & Africa Glucagon Drug Sales Quantity Market Share by Application (2019-2030)
    Figure 66. Middle East & Africa Glucagon Drug Sales Quantity Market Share by Region (2019-2030)
    Figure 67. Middle East & Africa Glucagon Drug Consumption Value Market Share by Region (2019-2030)
    Figure 68. Turkey Glucagon Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 69. Egypt Glucagon Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 70. Saudi Arabia Glucagon Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. South Africa Glucagon Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Glucagon Drug Market Drivers
    Figure 73. Glucagon Drug Market Restraints
    Figure 74. Glucagon Drug Market Trends
    Figure 75. Porters Five Forces Analysis
    Figure 76. Manufacturing Cost Structure Analysis of Glucagon Drug in 2023
    Figure 77. Manufacturing Process Analysis of Glucagon Drug
    Figure 78. Glucagon Drug Industrial Chain
    Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 80. Direct Channel Pros & Cons
    Figure 81. Indirect Channel Pros & Cons
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Companies Mentioned

Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Amphastar Pharmaceuticals
Xeris Pharmaceuticals